Evaluation of Pre-Therapeutic Assessment in Endometrial Cancer Staging
Abstract
:1. Introduction
2. Material and Method
2.1. Population
2.2. Statistical Method
3. Results
3.1. Population
3.2. Concordance between MRI and Final Histopathological Examination
3.3. Concordance between Endometrial Biopsy and Final Histopathological Examination
3.4. Indication of Lymphadenectomy
4. Discussion
4.1. Concordance between MRI and Final Histopathological Examination
4.2. Concordance between Endometrial Biopsy and Final Histopathological Examination
4.3. Strength and Limitation
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Epidémiologie Cancers féminins [Internet]. Available online: https://www.arcagy.org/infocancer/localisations/cancers-feminins/cancer-du-corps-de-l-uterus/maladie/avant-propos-et-epidemiologie.html/ (accessed on 26 February 2020).
- Lewin, S.N.; Herzog, T.J.; Medel, N.I.B.; Deutsch, I.; Burke, W.M.; Sun, X.; Wright, J.D. Comparative Performance of the 2009 International Federation of Gynecology and Obstetrics’ Staging System for Uterine Corpus Cancer. Obstet. Gynecol. 2010, 116, 1141–1149. [Google Scholar] [CrossRef] [PubMed]
- Amant, F.; Mirza, M.R.; Koskas, M.; Creutzberg, C.L. Cancer of the corpus uteri. Int. J. Gynecol. Obstet. 2018, 143, 37–50. [Google Scholar] [CrossRef] [Green Version]
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet 2009, 373, 125–136. [CrossRef] [Green Version]
- Creasman, W.T.; Morrow, C.P.; Bundy, B.N.; Homesley, H.D.; Graham, J.E.; Heller, P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987, 60, 2035–2041. [Google Scholar] [CrossRef]
- Boronow, R.C.; Morrow, C.P.; Creasman, W.T.; Disaia, P.J.; Silverberg, S.G.; Miller, A.; Blessing, J.A. Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstet. Gynecol. 1984, 63, 825–832. [Google Scholar]
- Colombo, N.; Preti, E.; Landoni, F.; Carinelli, S.; Colombo, A.; Marini, C.; Sessa, C. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013, 24, vi33–vi38. [Google Scholar] [CrossRef]
- Ouvrage collectif edit by InCa. Cancer de l’endomètre: Synthèse des recommandations [Internet]. Boulogne-Billancourt. 2010. Available online: https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Cancer-de-l-endometre-synthese-des-recommandations (accessed on 27 February 2020).
- Kilgore, L.C.; Partridge, E.E.; Alvarez, R.D.; Austin, J.M.; Shingleton, H.M.; Noojin, F.; Conner, W. Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling. Gynecol. Oncol. 1995, 56, 29–33. [Google Scholar] [CrossRef]
- Todo, Y.; Kato, H.; Kaneuchi, M.; Watari, H.; Takeda, M.; Sakuragi, N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): A retrospective cohort analysis. Lancet 2010, 375, 1165–1172. [Google Scholar] [CrossRef]
- Panici, P.B.; Basile, S.; Maneschi, F.; Lissoni, A.A.; Signorelli, M.; Scambia, G.; Scambia, G.; Angioli, R.; Tateo, S.; Mangili, G.; et al. Systematic Pelvic Lymphadenectomy vs. No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial. JNCI J. Natl. Cancer Inst. 2008, 100, 1707–1716. [Google Scholar] [CrossRef] [Green Version]
- May, K.; Bryant, A.; Dickinson, H.O.; Kehoe, S.; Morrison, J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst. Rev. 2010. [Google Scholar] [CrossRef]
- Agar, N.; Philippe, A.-C.; Bourdel, N.; Rabischong, B.; Canis, M.; Le Bouedec, G.; Mulliez, A.; Dauplat, J.; Pomel, C. Les lymphadénectomies dans le cancer de l’endomètre, bilan après 4ans de pratique, doit-on poursuivre? Bull. Cancer (Paris) 2015, 102, 428–435. [Google Scholar] [CrossRef] [PubMed]
- Undurraga, M.; Petignat, P.; Pelte, M.-F.; Jacob, S.; Dubuisson, J.-B.; Loubeyre, P. Magnetic resonance imaging to identify risk of lymph node metastasis in patients with endometrial cancer. Int. J. Gynecol. Obstet. 2009, 104, 233–235. [Google Scholar] [CrossRef] [PubMed]
- Luomaranta, A.; Leminen, A.; Loukovaara, M. Magnetic Resonance Imaging in the Assessment of High-Risk Features of Endometrial Carcinoma: A Meta-Analysis. Int. J. Gynecol. Cancer 2015, 25, 837–842. [Google Scholar] [CrossRef]
- Rodríguez-Trujillo, A.; Martínez-Serrano, M.J.; Martínez-Román, S.; Martí, C.; Buñesch, L.; Nicolau, C.; Pahisa, J. Preoperative Assessment of Myometrial Invasion in Endometrial Cancer by 3D Ultrasound and Diffusion-Weighted Magnetic Resonance Imaging: A Comparative Study. Int. J. Gynecol. Cancer 2016, 26, 1105–1110. [Google Scholar] [CrossRef] [PubMed]
- Luomaranta, A.; Bützow, R.; Pauna, A.-R.; Leminen, A.; Loukovaara, M. Combined use of endometrial sample and magnetic resonance imaging in the preoperative risk-stratification of endometrial carcinomas. Acta Obstet. Gynecol. Scand. 2015, 94, 95–101. [Google Scholar] [CrossRef]
- Kong, A.; Johnson, N.; Kitchener, H.C.; Lawrie, T.A. Adjuvant radiotherapy for stage I endometrial cancer. In Cochrane Database of Systematic Reviews; The Cochrane Collaboration, Ed.; John Wiley & Sons, Ltd.: Chichester, UK, 2012; p. 003916. [Google Scholar]
- Kim, H.S.; Suh, D.H.; Kim, M.-K.; Chung, H.H.; Park, N.H.; Song, Y.S. Systematic Lymphadenectomy for Survival in Patients with Endometrial Cancer: A Meta-analysis. Jpn. J. Clin. Oncol. 2012, 42, 405–412. [Google Scholar] [CrossRef] [Green Version]
- Look, K.Y. Role of lymphadenectomy in management of adenocarcinoma of the endometrium. Eur. J. Gynecol. Oncol. 2004, 25, 545–551. [Google Scholar]
- Morice, P.; Leary, A.; Creutzberg, C.; Abu-Rustum, N.; Darai, E. Endometrial cancer. Lancet 2016, 387, 1094–1108. [Google Scholar] [CrossRef]
- Frost, J.A.; Webster, K.E.; Bryant, A.; Morrison, J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst. Rev. 2017. [Google Scholar] [CrossRef] [Green Version]
- Coussoou, C.; Laigle-Quérat, V.; Loussouarn, D.; Vaucel, E.; Frampas, E. Performances de l’IRM dans le bilan d’extension locale préopératoire des cancers de l’endomètre: L’expérience nantaise. Gynécologie Obstétrique Fertilité Sénologie 2020, 48, 374–383. [Google Scholar] [CrossRef]
- Bi, Q.; Chen, Y.; Wu, K.; Wang, J.; Zhao, Y.; Wang, B.; Du, J. The Diagnostic Value of MRI for Preoperative Staging in Patients with Endometrial Cancer: A Meta-Analysis. Acad. Radiol. 2020, 27, 960–968. [Google Scholar] [CrossRef] [PubMed]
- Rei, M.; Rodrigues, I.; Condeço, P.; Igreja, F.; Veríssimo, C.; Mendinhos, G. Endometrial cancer: Preoperative versus intraoperative staging. J. Gynecol. Obstet. Hum. Reprod. 2020, 49, 101647. [Google Scholar] [CrossRef] [PubMed]
- Novellas, S.; Fournol, M.; Caramella, T.; Marcotte-Bloch, C.; Bafghi, A.; Bongain, A.; Chevallier, P. Évaluation en imagerie par résonance magnétique des carcinomes de l’endomètre. J. Radiol. 2008, 89, 1711–1720. [Google Scholar] [CrossRef]
- Boran, N.; Akdag, D.; Halici, F.; Tulunay, G.; Turan, T.; Bozok, S.; Erdogan, Z.; Kose, M.F. A retrospective analysis of the diameter of metastatic lymph nodes in apparently early stage endometrial cancer. Tumori 2008, 94, 681–685. [Google Scholar] [CrossRef] [PubMed]
- Kitajima, K.; Yamasaki, E.; Kaji, Y.; Murakami, K.; Sugimura, K. Comparison of DWI and PET/CT in evaluation of lymph node metastasis in uterine cancer. World J. Radiol. 2012, 4, 207–214. [Google Scholar] [CrossRef] [PubMed]
- Lai, C.-H.; Lin, G.; Yen, T.-C.; Liu, F.-Y. Molecular imaging in the management of gynecologic malignancies. Gynecol. Oncol. 2014, 135, 156–162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Groheux, D.; Hindié, E.; Trédaniel, J.; Giraudet, A.-L.; Vaylet, F.; Berenger, N.; Moretti, J.-L. TEP-TDM pour l’exploration du nodule pulmonaire solitaire: Acquis et perspectives. Rev. Mal. Respir. 2009, 26, 1041–1055. [Google Scholar] [CrossRef]
- Stanzione, A.; Cuocolo, R.; Del Grosso, R.; Nardiello, A.; Romeo, V.; Travaglino, A. Deep Myometrial Infiltration of Endometrial Cancer on MRI: A Radiomics-Powered Machine Learning Pilot Study. Acad. Radiol. 2020. [Google Scholar] [CrossRef]
- Ballester, M.; Dubernard, G.; Lécuru, F.; Heitz, D.; Mathevet, P.; Marret, H.; Querleu, D.; Golfier, F.; Leblanc, E.; Rouzier, R. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: A prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011, 12, 469–476. [Google Scholar] [CrossRef]
- How, J.A.; O’farrell, P.; Amajoud, Z.; Lau, S.; Salvador, S.; How, E.; Gotlieb, W.H. Sentinel lymph node mapping in endometrial cancer: A systematic review and meta-analysis. Minerva Ginecol. 2018, 70, 194–214. [Google Scholar]
- Bodurtha Smith, A.J.; Fader, A.N.; Tanner, E.J. Sentinel lymph node assessment in endometrial cancer: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2017, 216, 459–476. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rossi, E.C.; Kowalski, L.D.; Scalici, J.; Cantrell, L.; Schuler, K.; Hanna, R.K.; Method, M.; Ade, M.; Ivanova, A.; Boggess, J.F. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): A multicentre, prospective, cohort study. Lancet Oncol. 2017, 18, 384–392. [Google Scholar] [CrossRef]
- Koh, W.-J.; Abu-Rustum, N.R.; Bean, S.; Bradley, K.; Campos, S.M.; Cho, K.R.; Chon, H.S.; Chu, C.; Cohn, D.; Crispens, M.A.; et al. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. 2018, 16, 170–799. [Google Scholar] [CrossRef] [Green Version]
- Lu, K.H.; Broaddus, R.R. Endometrial Cancer. N. Engl. J. Med. 2020, 383, 2053–2064. [Google Scholar] [CrossRef] [PubMed]
- Frumovitz, M.; Singh, D.K.; Meyer, L.; Smith, D.H.; Wertheim, I.; Resnik, E.; Bodurka, D.C. Predictors of final histology in patients with endometrial cancer. Gynecol. Oncol. 2004, 95, 463–468. [Google Scholar] [CrossRef]
- Mitchard, J.; Hirschowitz, L. Concordance of FIGO grade of endometrial adenocarcinomas in biopsy and hysterectomy specimens. Histopathology 2003, 42, 372–378. [Google Scholar] [CrossRef]
- Wang, X.; Huang, Z.; Di, W.; Lin, Q. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients. Arch. Gynecol. Obstet. 2005, 272, 136–141. [Google Scholar]
- Scholten, A.N.; Smit, V.T.H.B.M.; Beerman, H.; van Putten, W.L.J.; Creutzberg, C.L. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma. Cancer 2004, 100, 764–772. [Google Scholar] [CrossRef]
- Nofech-Mozes, S.; Ismiil, N.; Dubé, V.; Saad, R.S.; Ghorab, Z.; Grin, A.; Ackerman, I.; Khalifa, M.A. Interobserver Agreement for Endometrial Cancer Characteristics Evaluated on Biopsy Material. Obstet. Gynecol. Int. 2012, 2012, 414086. [Google Scholar] [CrossRef]
- Leitao, M.M.; Kehoe, S.; Barakat, R.R.; Alektiar, K.; Gattoc, L.P.; Rabbitt, C. Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol. Oncol. 2009, 113, 105–108. [Google Scholar]
- The American College of Obstetricians and Gynecologists: Women’s health care physicians. Obstet. Gynecol. 2018, 131. [CrossRef]
- Chang, Y.-N.; Zhang, Y.; Wang, Y.-J.; Wang, L.-P.; Duan, H. Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: A meta-analysis. Fertil. Steril. 2011, 96, 957–961. [Google Scholar] [CrossRef] [PubMed]
- Schwartz, M.; Gavane, S.C.; Bou-Ayache, J.; Kolev, V.; Zakashansky, K.; Prasad-Hayes, M. Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: A prospective pilot study. Abdom Radiol. 2018, 43, 3462–3467. [Google Scholar] [CrossRef] [PubMed]
- Bian, L.-H.; Wang, M.; Gong, J.; Liu, H.-H.; Wang, N.; Wen, N.; Fan, W.-S.; Xu, B.-X.; Wang, M.-Y.; Ye, M.-X.; et al. Comparison of integrated PET/MRI with PET/CT in evaluation of endometrial cancer: A retrospective analysis of 81 cases. PeerJ 2019, 7, e7081. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fernandez, C.M.; Levine, E.M.; Dini, M.; Bannon, K.; Butler, S.; Locher, S. Predictive Value of Three-Dimensional Transvaginal Sonography for Staging of Endometrial Neoplasia. J. Diagn Med. Sonogr. 2018, 34, 496–500. [Google Scholar] [CrossRef]
Age (years old) (Median, SD) (N = 183) | 66.1 (10.1) |
BMI (kg/m2) (Median, SD) (N = 183) | 39 (14.5) |
ASA score (n, %) (N = 170) | |
1 | 29 (17.1) |
2 | 76 (44.7) |
3 | 61 (35.9) |
4 | 4 (2.4) |
Menopausal status (n, %) (N = 182) | |
Premenopausal | 6 (3.3) |
Postmenopausal | 176 (96.7) |
Hormone replacement therapy (n, %) (N = 155) | 28 (18.1) |
Tamoxifen (n, %) (N = 182) | 12 (6.6) |
Parity (median, range) (N = 171) | 2 (0–9) |
Abnormal bleedings (n, %) (N = 183) | 166 (90.7) |
Diabetes (n, %) (N = 183) | 40 (21.9) |
FIGO Stage | Final Histopathological Examination (n, %) | N (n, %) | ||||
---|---|---|---|---|---|---|
IA | IB | II | III–IV | |||
MRI | IA | 36 (37.5) | 36 (37.5) | 11 (11.5) | 13 (13.5) | 96 (53.9) |
IB | 21 (50.0) | 11 (26.2) | 5 (11.9) | 5 (11.9) | 42 (23.6) | |
II | 3 (17.6) | 4 (23.5) | 4 (23.5) | 6 (35.3) | 17 (9.6) | |
III–IV | 6 (26.1) | 6 (26.1) | 3 (13.0) | 8 (34.8) | 23 (12.9) | |
N (n, %) | 66 (37.1) | 57 (32.0) | 23 (12.9) | 32 (18.0) | 178 |
Final Histopathological Examination (n, %) | ||||
---|---|---|---|---|
N− | N+ | |||
MRI | N− | 101 (87.1) | 15 (12.9) | 116 |
N+ | 8 (66.7) | 4 (33.3) | 12 | |
109 | 19 |
Tumor Grade | Final Histopathological Examination (n, %) | N (n, %) | |||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Endometrial biopsy | 1 | 37 (49.3) | 35 (46.7) | 3 (4.0) | 75 (43.4) |
2 | 5 (7.6) | 49 (74.2) | 12 (18.2) | 66 (38.2) | |
3 | 1 (3.1) | 6 (18.8) | 25 (78.1) | 32 (18.5) | |
N (n, %) | 43 (24.9) | 90 (52.0) | 40 (23.1) | 173 |
Tumor Grade | Final Histopathological Examination (n, %) | N (n, %) | |||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Cornier pipelle (n, %) | 1 | 13 (34.2) | 22 (57.9) | 3 (7.9) | 38 |
2 | 2 (6.5) | 22 (71.0) | 7 (22.6) | 31 | |
3 | 0 | 0 | 12 (100) | 12 | |
Hysteroscopy (n, %) | 1 | 24 (64.9) | 13 (35.1) | 0 | 37 |
2 | 3 (8.6) | 27 (77.1) | 5 (14.3) | 35 | |
3 | 1 (5.0) | 6 (30.0) | 13 (65.0) | 20 | |
N (n, %) | 43 (24.9) | 90 (52.0) | 40 (23.1) | 173 |
Indication of Lymphadenectomy on Postoperative Data (n/N) | |||||
---|---|---|---|---|---|
Indication of lymphadenectomy on preoperative data (n/N) | Indicated | Not Indicated | Performed | Nodal Metastasis | |
Indicated | 50/66 | 16/66 | 58/66 | 13/58 | |
Not indicated | 42/106 | 64/106 | 70/106 | 6/70 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bouche, C.; Gomes David, M.; Salleron, J.; Rauch, P.; Leufflen, L.; Buhler, J.; Marchal, F. Evaluation of Pre-Therapeutic Assessment in Endometrial Cancer Staging. Diagnostics 2020, 10, 1045. https://doi.org/10.3390/diagnostics10121045
Bouche C, Gomes David M, Salleron J, Rauch P, Leufflen L, Buhler J, Marchal F. Evaluation of Pre-Therapeutic Assessment in Endometrial Cancer Staging. Diagnostics. 2020; 10(12):1045. https://doi.org/10.3390/diagnostics10121045
Chicago/Turabian StyleBouche, Caroline, Manuel Gomes David, Julia Salleron, Philippe Rauch, Léa Leufflen, Julie Buhler, and Frédéric Marchal. 2020. "Evaluation of Pre-Therapeutic Assessment in Endometrial Cancer Staging" Diagnostics 10, no. 12: 1045. https://doi.org/10.3390/diagnostics10121045